pimagedine has been researched along with lc15-0444 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, MH; Jung, E; Kim, J; Kim, S; Kim, SH | 1 |
1 other study(ies) available for pimagedine and lc15-0444
| Article | Year |
|---|---|
Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.
Topics: Animals; Collagen; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosylation; Guanidines; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Piperidones; Pyrimidines; Rats; Serum Albumin, Bovine | 2014 |